255706-13-9 Usage
Description
Dabigatran Etexilate iMpurity I is an impurity found in Dabigatran (D100090), a nonpeptide, direct thrombin inhibitor with antithrombotic properties. It is a compound that arises during the synthesis process of Dabigatran and may have different applications depending on the industry it is used in.
Uses
Used in Pharmaceutical Industry:
Dabigatran Etexilate iMpurity I is used as a reference compound for the development and validation of analytical methods, quality control, and stability testing of Dabigatran Etexilate. This helps ensure the purity, safety, and efficacy of the final drug product.
Used in Research and Development:
Dabigatran Etexilate iMpurity I is used as a research tool in the study of thrombin inhibition and antithrombotic effects. It aids in understanding the mechanism of action, pharmacokinetics, and potential side effects of Dabigatran Etexilate, contributing to the advancement of thrombin inhibitor research.
Used in Quality Control:
Dabigatran Etexilate iMpurity I is used as a control substance in the quality control process of Dabigatran Etexilate manufacturing. It helps in the identification, quantification, and control of impurities in the final drug product, ensuring that the product meets the required quality standards.
Used in Regulatory Compliance:
Dabigatran Etexilate iMpurity I is used in the regulatory compliance process to demonstrate the ability of the manufacturing process to control and eliminate impurities. This is essential for obtaining regulatory approval and ensuring the safety and efficacy of Dabigatran Etexilate as a pharmaceutical product.
Check Digit Verification of cas no
The CAS Registry Mumber 255706-13-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,5,5,7,0 and 6 respectively; the second part has 2 digits, 1 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 255706-13:
(8*2)+(7*5)+(6*5)+(5*7)+(4*0)+(3*6)+(2*1)+(1*3)=139
139 % 10 = 9
So 255706-13-9 is a valid CAS Registry Number.
255706-13-9Relevant articles and documents
Refining method of Dabigatran etexilate intermediate condensation compound
-
Paragraph 0016; 0017, (2016/10/10)
The invention relates to a refining method of a Dabigatran etexilate intermediate condensation compound, and belongs to the technical field of medicine purification.The method includes the steps of adding acetone to the Dabigatran etexilate intermediate c
